Navigation Links
New PrEP Trial Results Among Injecting Drug Users Underscore That PrEP Works When Taken Consistently
Date:6/12/2013

NEW YORK, June 12, 2013 /PRNewswire-USNewswire/ -- Results from the Bangkok Tenofovir Study published online today in The Lancet provide additional evidence that daily oral tenofovir-based pre-exposure prophylaxis (PrEP) reduces HIV infection risk when taken consistently. The results from the study—the first conducted among people who inject drugs—are consistent with previous studies among men and women primarily at risk of acquiring HIV through sex. They provide additional support for moving forward to ensure that people who can benefit from PrEP have access to it.

"These results underscore what we've learned in a range of studies—daily tenofovir-based PrEP works when you take it," said Mitchell Warren, AVAC executive director. "Although there is more to learn about how this or other PrEP strategies work in men and women who inject drugs, this study offers the first indication that oral PrEP may reduce the risk of HIV infection via needle exposure. Comprehensive harm reduction, along with human rights protections, are the fundamental HIV prevention tools for injecting drug users. We need to continue to roll out proven prevention and find out more about how this oral PrEP strategy might work in a group that is at very high risk for HIV infection and has too often been ignored."

"We now need to get serious about making PrEP available to those who can benefit. More than two and a half years after the first positive results from a PrEP trial, little has been done to answer critical questions about the best ways to roll out daily oral PrEP to key populations worldwide. Within the next year, a comprehensive package of demonstration projects should be planned, funded and launched in countries around the world," Warren said.

Data from previous oral PrEP studies showed varying levels of effectiveness of tenofovir-based prevention for heterosexual men and women, and for men
'/>"/>

SOURCE AVAC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
2. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
3. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
4. SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
5. AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management
6. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
7. Inspiro Medical Ltd. Completes a Successful First Clinical Trial in Asthmatic Children
8. Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials
9. TransCelerate BioPharma Inc. Reveals Collaborative Methodology for Risk-Based Monitoring of Clinical Trials
10. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
11. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Critical Process Filtration, ... , today announces the expansion of their Technical ... Process Filtration now offers customers and potential customers ... to filter failure analyses (even for competitor filters) ... their hallmark services of system benchmarking and cost/performance ...
(Date:8/28/2014)... -- Rx Safes, Inc., the manufacturer of fingerprint recognition home ... new war on drugs to reduce prescription drug abuse, ... than 2,500 children a day experiment with prescription drugs ... accessed from unsecured medicine cabinets, closets and drawers.  While law ... Safes will address the new age drug dealer in ...
(Date:8/28/2014)... , Californie, 28 août 2014 ... annoncé aujourd,hui le début des inclusions ... étude  d,exemption des dispositifs expérimentaux (ou ... à évaluer l,innocuité et l,efficacité du ... Le docteur Adam Arthur , ...
Breaking Medicine Technology:Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support 2Rx Safes, Inc. Announces New War On Drugs 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4
... NOVI, Mich., Jan. 10, 2011 Nopras ... firm which specializes in services for organizations in ... regulated industries announced on January 10th, 2011 that ... Nopras Technologies, well documented procedures and ...
... N.J., Jan. 10, 2011 MedAvante, Inc., the ... central nervous system (CNS) disorders, announced the appointment ... position of Vice President, Neurocognition.  Dr. Randolph will ... experts and experienced, calibrated clinicians focusing on Alzheimer,s ...
Cached Medicine Technology:Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification 2MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area 2MedAvante Names Leading Expert to Head Neurocognition Therapeutic Area 3
(Date:8/28/2014)... cent of rheumatoid arthritis patients in the study who ... therapies did not take them as prescribed in the ... among those from 60 hospitals around the UK involved ... UK Centre for Genetics and Genomics at The University ... to take the drugs correctly, known as ,non-adherence, reduced ...
(Date:8/28/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... AND GLOBAL MARKETS , the global market for surgical ... Driven by the need for replacement of existing installations ... geographies, the market is expected to grow to $631.9 ... 8.5% from 2013 through 2018. , While revenue generation ...
(Date:8/28/2014)... Canadian Linen and Uniform Service, a leading textile ... the launch of its new Customer Portal, an online ... even easier and more convenient for customers. The industry-leading ... and better communicate with the company. , Features of ... , Access, download and pay bills online ...
(Date:8/28/2014)... Parker Waichman LLP, a national personal ... to ensure that the heroes of 9/11 are never ... WTC victims who developed 9/11-related cancer was reaffirmed by ... (GAO). According to a statement issued by 9/11 ... entitled “World Trade Center Health Program: Approach Used to ...
(Date:8/28/2014)... Siena Farms , in partnership with ... Kids’ Share, which is designed for children ages 6-12. The ... to get into the kitchen, have some fun, and cook ... the Kids’ Share will be themed and recipe-focused. In addition ... kids, recipes from ChopChop Magazine: The Fun Cooking Magazine for ...
Breaking Medicine News(10 mins):Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 2Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 4
... have developed an effective technique that uses gene therapy on ... culture, which could eventually serve as a treatment for this ... published in Blood , the Journal of ... a type of white blood cell of the immune system, ...
... common in Germany compared with the rest of Europe. Extensive ... in 85-100% of cases, Wolfgang Herrmann and Rima Obeid argue ... Arztebl Int 2011; 108[15]; 249-54). A woman,s folic acid ... does not develop the neural tube defect commonly known as ...
... The largest study of its type has found that ... drug metformin, successfully reduced liver enzymes in nonalcoholic fatty liver ... in the April 27, 2011 issue of Journal of ... in patients with a severe type of fatty liver disease, ...
... oncologist practiced were two factors that strongly influenced the choice ... to an article published April 29 online in the ... IMRT and the cost of radiation therapy increased sharply over ... delivery technique that modulates the radiation beams to conform to ...
... with the Japanese Bone and Mineral Research Society, invite ... bone research to attend the year,s most important bone ... Gold Coast in Queensland, Australia, the congress will present ... on the latest advances in the clinical management of ...
... , THURSDAY, April 28 (HealthDay News) -- ... may already know: the illness can greatly diminish quality of ... took part in the national Behavioral Risk Factor Surveillance ... health was reported by 27 percent of respondents with arthritis ...
Cached Medicine News:Health News:New gene therapy technique on iPS cells holds promise in treating immune system disease 2Health News:New gene therapy technique on iPS cells holds promise in treating immune system disease 3Health News:JAMA study reports on fatty liver disease in children and teens 2Health News:Use of costly breast cancer therapy strongly influenced by reimbursement policy 2Health News:Preliminary program announced for 2nd Asia-Pacific Osteoporosis & Bone Meeting 2Health News:Study Highlights Arthritis' Toll on Quality of Life 2
... Single use curved circular ... and titanium staples., ,The ... stapler is used throughout the ... of end-to-end, end-to-side and side-to-side ...
... The Scantibodies Calcitonin Immunoassay is a two-site ... calcitonin. Two different goat polyclonal antibodies to ... chromatography to be specific for well-defined regions ... quantitative determination of Calcitonin in human serum. ...
Calcitonin RIA Kit...
... IMAGE1 is the first completely digital camera ... in the field of endoscopic camera systems. ... the first time, facilitates the fully digital ... quality using an A/D converter, as well ...
Medicine Products: